Literature DB >> 8978457

Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth.

A Hatzoglou1, E Bakogeorgou, E Papakonstanti, C Stournaras, D S Emmanouel, E Castanas.   

Abstract

Opioids and somatostatin analogs have been implicated in the modulation of renal water handling, but whether their action is accomplished through central and/or peripheral mechanisms remains controversial. In different cell systems, on the other hand, opioids and somatostatin inhibit cell proliferation. In the present study, we have used an established cell line, derived from opossum kidney (OK) proximal tubules, in order to characterize opioid and somatostatin receptors and to investigate the action of opioids and somatostatin on tubular epithelial tissue. Our results show the presence of one class of opioid binding sites with kappa, selectivity (KD 4.6 +/- 0.9 nM, 57,250 sites/cell), whereas delta, mu, or other subtypes of the kappa site were absent. Somatostatin presents also a high affinity site on these cells (KD 24.5 nM, 330,000 sites/cell). No effect of either opioids or somatostatin on the activity of the NA+/Pi cotransporter was observed, indicating that these agents do not affect ion transport mechanisms. However, opioid agonists and somatostatin analogs decrease OK cell proliferation in a dose-dependent manner; in the same nanomolar concentration range, they displayed reversible specific binding for these agents. The addition of diprenorphine, a general opioid antagonist, reversed the effects of opioids, with the exception of morphine. Furthermore, morphine interacts with the somatostatin receptor in this cell line too, as was the case in the breast cancer T47D cell line. Our results indicate that in the proximal tubule opioids and somatostatin do not affect transport, but they might have a role in the modulation of renal cell proliferation either during ontogenesis or in kidney repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8978457     DOI: 10.1002/(SICI)1097-4644(19961215)63:4%3C410::AID-JCB3%3E3.0.CO;2-W

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.

Authors:  A Lianne Messchendorp; Edwin M Spithoven; Niek F Casteleijn; Wendy A Dam; Jacob van den Born; Wouter F Tonnis; Carlo A J M Gaillard; Esther Meijer
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

Review 2.  Morphine: double-faced roles in the regulation of tumor development.

Authors:  X Y Zhang; Y X Liang; Y Yan; Z Dai; H C Chu
Journal:  Clin Transl Oncol       Date:  2017-11-10       Impact factor: 3.405

3.  Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.

Authors:  Sunil Bhandari; Neil Watson; Ervine Long; Steve Sharpe; Wenwen Zhong; Shang-Zhong Xu; Stephen L Atkin
Journal:  J Histochem Cytochem       Date:  2008-04-28       Impact factor: 2.479

4.  Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization.

Authors:  Evangelia A Papakonstanti; Christos Stournaras
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

5.  Receptorphin: a conserved peptide derived from the sequence of the opioid receptor, with opioid displacement activity and potent antiproliferative actions in tumor cells.

Authors:  M Kampa; S Loukas; A Tsapis; E Castanas
Journal:  BMC Pharmacol       Date:  2001-11-27

6.  Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression.

Authors:  Sabrina Bimonte; Antonio Barbieri; Domenica Rea; Giuseppe Palma; Antonio Luciano; Arturo Cuomo; Claudio Arra; Francesco Izzo
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

7.  Effects of octreotide and insulin on colon cancer cellular proliferation and correlation with hTERT activity.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Ioannis Drygiannakis; Maria Georgiadou; Ourania Sfakianaki; Niki Mastrodimou; Kyriaki Thermos; Elias Kouroumalis
Journal:  Oncoscience       Date:  2014-06-30

8.  Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells.

Authors:  Céline Kerros; Thibault Cavey; Brigitte Sola; Philippe Jauzac; Stéphane Allouche
Journal:  J Exp Clin Cancer Res       Date:  2009-06-07

Review 9.  The role of morphine in animal models of human cancer: does morphine promote or inhibit the tumor growth?

Authors:  Sabrina Bimonte; Antonio Barbieri; Giuseppe Palma; Claudio Arra
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

10.  The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells.

Authors:  Sabrina Bimonte; Antonio Barbieri; Marco Cascella; Domenica Rea; Giuseppe Palma; Vitale Del Vecchio; Cira Antonietta Forte; Francesco Del Prato; Claudio Arra; Arturo Cuomo
Journal:  Onco Targets Ther       Date:  2018-01-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.